| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drosophila melanogaster | 3 | 2018 | 168 | 1.240 |
Why?
|
| Apoptosis | 7 | 2023 | 1317 | 1.140 |
Why?
|
| RNA, Untranslated | 8 | 2013 | 42 | 1.130 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2021 | 13 | 1.110 |
Why?
|
| RNA | 4 | 2023 | 234 | 1.090 |
Why?
|
| Chromatin | 6 | 2018 | 164 | 1.080 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2021 | 34 | 0.980 |
Why?
|
| Metabolic Diseases | 1 | 2023 | 32 | 0.930 |
Why?
|
| Fatty Liver | 1 | 2023 | 56 | 0.910 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 55 | 0.910 |
Why?
|
| Furin | 1 | 2022 | 5 | 0.860 |
Why?
|
| Antibodies, Neutralizing | 2 | 2022 | 102 | 0.860 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2022 | 17 | 0.850 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2022 | 40 | 0.830 |
Why?
|
| Guanine | 1 | 2021 | 45 | 0.800 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 195 | 0.790 |
Why?
|
| DNA Damage | 3 | 2020 | 341 | 0.780 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 252 | 0.770 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 303 | 0.740 |
Why?
|
| Fluorine Radioisotopes | 1 | 2019 | 11 | 0.730 |
Why?
|
| Gamma Rays | 1 | 2019 | 25 | 0.730 |
Why?
|
| Genomic Imprinting | 5 | 2013 | 35 | 0.730 |
Why?
|
| Environmental Pollutants | 1 | 2022 | 166 | 0.720 |
Why?
|
| Chromosome Aberrations | 1 | 2019 | 56 | 0.700 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 592 | 0.690 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2018 | 71 | 0.690 |
Why?
|
| Histones | 6 | 2021 | 177 | 0.690 |
Why?
|
| Drosophila Proteins | 2 | 2018 | 162 | 0.680 |
Why?
|
| Humans | 39 | 2024 | 34853 | 0.680 |
Why?
|
| SOX9 Transcription Factor | 1 | 2018 | 10 | 0.650 |
Why?
|
| Epigenesis, Genetic | 5 | 2021 | 198 | 0.650 |
Why?
|
| Fibroblasts | 1 | 2019 | 252 | 0.640 |
Why?
|
| DNA, Plant | 1 | 2017 | 13 | 0.630 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 126 | 0.630 |
Why?
|
| Genome, Plant | 1 | 2017 | 26 | 0.630 |
Why?
|
| Benzoxazoles | 1 | 2017 | 9 | 0.620 |
Why?
|
| Crops, Agricultural | 1 | 2017 | 30 | 0.610 |
Why?
|
| Plants | 1 | 2017 | 94 | 0.580 |
Why?
|
| Triazoles | 1 | 2017 | 85 | 0.580 |
Why?
|
| RNA, Viral | 3 | 2023 | 287 | 0.570 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 968 | 0.570 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2020 | 781 | 0.560 |
Why?
|
| Transcription, Genetic | 5 | 2018 | 550 | 0.530 |
Why?
|
| Plant Roots | 1 | 2017 | 153 | 0.530 |
Why?
|
| MicroRNAs | 2 | 2017 | 386 | 0.520 |
Why?
|
| Animals | 22 | 2021 | 14307 | 0.470 |
Why?
|
| Neuroblastoma | 3 | 2020 | 128 | 0.460 |
Why?
|
| Cytochrome P-450 CYP2D6 | 2 | 2022 | 17 | 0.440 |
Why?
|
| Cell Line, Tumor | 8 | 2020 | 2128 | 0.420 |
Why?
|
| Hepacivirus | 2 | 2008 | 59 | 0.410 |
Why?
|
| Gene Silencing | 6 | 2013 | 143 | 0.400 |
Why?
|
| Cephalometry | 1 | 2011 | 24 | 0.400 |
Why?
|
| Skull | 1 | 2011 | 35 | 0.400 |
Why?
|
| Cell Line | 6 | 2019 | 1289 | 0.390 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2021 | 37 | 0.390 |
Why?
|
| Face | 1 | 2011 | 49 | 0.380 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 164 | 0.360 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 282 | 0.360 |
Why?
|
| Gene Expression Profiling | 4 | 2023 | 600 | 0.360 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2018 | 41 | 0.350 |
Why?
|
| Glycolysis | 2 | 2019 | 66 | 0.340 |
Why?
|
| Genomics | 2 | 2022 | 201 | 0.340 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 123 | 0.340 |
Why?
|
| Ribonucleoproteins | 1 | 2008 | 29 | 0.340 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 209 | 0.340 |
Why?
|
| Cell Proliferation | 3 | 2021 | 1149 | 0.330 |
Why?
|
| Autoantigens | 1 | 2008 | 82 | 0.330 |
Why?
|
| Algorithms | 1 | 2011 | 435 | 0.320 |
Why?
|
| Mice | 14 | 2021 | 5668 | 0.300 |
Why?
|
| Epitopes | 2 | 2023 | 145 | 0.280 |
Why?
|
| Neoplasms | 3 | 2021 | 1033 | 0.280 |
Why?
|
| RNA, Antisense | 3 | 2011 | 17 | 0.270 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2022 | 180 | 0.240 |
Why?
|
| Amino Acid Sequence | 2 | 2022 | 1124 | 0.240 |
Why?
|
| Fas Ligand Protein | 1 | 2023 | 16 | 0.240 |
Why?
|
| Antibodies | 1 | 2023 | 135 | 0.230 |
Why?
|
| Immunotherapy | 2 | 2021 | 91 | 0.230 |
Why?
|
| Cricetulus | 2 | 2020 | 74 | 0.230 |
Why?
|
| Methylation | 1 | 2023 | 102 | 0.230 |
Why?
|
| District of Columbia | 1 | 2022 | 68 | 0.220 |
Why?
|
| Methyltransferases | 1 | 2023 | 56 | 0.220 |
Why?
|
| Slovakia | 1 | 2022 | 7 | 0.220 |
Why?
|
| Dyslipidemias | 1 | 2022 | 42 | 0.210 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2021 | 9 | 0.210 |
Why?
|
| Virus Internalization | 1 | 2022 | 27 | 0.210 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 129 | 0.210 |
Why?
|
| Female | 12 | 2023 | 19873 | 0.200 |
Why?
|
| Pilot Projects | 1 | 2023 | 628 | 0.200 |
Why?
|
| Immune Evasion | 1 | 2021 | 16 | 0.200 |
Why?
|
| rho-Associated Kinases | 1 | 2021 | 30 | 0.200 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 27 | 0.200 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 341 | 0.200 |
Why?
|
| Antibodies, Bispecific | 1 | 2020 | 1 | 0.190 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 117 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 104 | 0.190 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2018 | 25 | 0.190 |
Why?
|
| Mitochondria | 3 | 2020 | 454 | 0.190 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 179 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 338 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 283 | 0.180 |
Why?
|
| Environmental Exposure | 1 | 2022 | 207 | 0.180 |
Why?
|
| Chromatids | 1 | 2019 | 3 | 0.180 |
Why?
|
| Carbocyanines | 1 | 2019 | 14 | 0.180 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 69 | 0.180 |
Why?
|
| Aneuploidy | 1 | 2019 | 20 | 0.180 |
Why?
|
| Karyotyping | 1 | 2019 | 46 | 0.180 |
Why?
|
| Chromosomes | 1 | 2019 | 35 | 0.180 |
Why?
|
| Benzimidazoles | 1 | 2019 | 36 | 0.180 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 17 | 0.180 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 71 | 0.180 |
Why?
|
| Body Weight | 1 | 2021 | 404 | 0.170 |
Why?
|
| Aerobiosis | 1 | 2019 | 15 | 0.170 |
Why?
|
| Whole Body Imaging | 1 | 2019 | 25 | 0.170 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 178 | 0.170 |
Why?
|
| Male | 9 | 2021 | 18870 | 0.170 |
Why?
|
| Gallbladder Neoplasms | 1 | 2018 | 1 | 0.170 |
Why?
|
| Comet Assay | 1 | 2019 | 72 | 0.170 |
Why?
|
| DNA Methylation | 2 | 2012 | 301 | 0.170 |
Why?
|
| Mitosis | 1 | 2019 | 97 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 200 | 0.170 |
Why?
|
| Child, Preschool | 2 | 2022 | 1318 | 0.170 |
Why?
|
| Ubiquitination | 1 | 2018 | 54 | 0.170 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 416 | 0.170 |
Why?
|
| Contrast Media | 1 | 2019 | 95 | 0.170 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 74 | 0.170 |
Why?
|
| Phosphorylation | 2 | 2019 | 878 | 0.160 |
Why?
|
| DNA Repair | 1 | 2019 | 181 | 0.160 |
Why?
|
| Cell Cycle | 1 | 2019 | 309 | 0.160 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2018 | 31 | 0.160 |
Why?
|
| Workflow | 1 | 2018 | 19 | 0.160 |
Why?
|
| S Phase | 1 | 2018 | 36 | 0.160 |
Why?
|
| Chromosomes, Plant | 1 | 2017 | 3 | 0.160 |
Why?
|
| Metagenomics | 1 | 2017 | 32 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 247 | 0.160 |
Why?
|
| Organogenesis | 1 | 2017 | 16 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2017 | 74 | 0.150 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 48 | 0.150 |
Why?
|
| Symbiosis | 1 | 2017 | 42 | 0.150 |
Why?
|
| Eye | 1 | 2018 | 68 | 0.150 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 159 | 0.150 |
Why?
|
| History, 20th Century | 1 | 2017 | 110 | 0.150 |
Why?
|
| Genetic Markers | 1 | 2017 | 118 | 0.150 |
Why?
|
| Caspases | 1 | 2017 | 132 | 0.150 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 184 | 0.150 |
Why?
|
| Lung | 1 | 2019 | 413 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 484 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2021 | 242 | 0.140 |
Why?
|
| Antioxidants | 1 | 2019 | 386 | 0.140 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2012 | 2 | 0.140 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 34 | 0.130 |
Why?
|
| Neuropeptides | 1 | 2015 | 57 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 336 | 0.130 |
Why?
|
| Child | 2 | 2022 | 2875 | 0.130 |
Why?
|
| Protein Conformation | 2 | 2021 | 350 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2018 | 522 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 183 | 0.120 |
Why?
|
| Models, Biological | 1 | 2017 | 642 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 229 | 0.120 |
Why?
|
| United States | 1 | 2022 | 3894 | 0.110 |
Why?
|
| Conserved Sequence | 2 | 2010 | 106 | 0.110 |
Why?
|
| DNA | 1 | 2015 | 549 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 1530 | 0.100 |
Why?
|
| Cell Nucleolus | 2 | 2008 | 9 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2021 | 1802 | 0.100 |
Why?
|
| Young Adult | 1 | 2021 | 4012 | 0.100 |
Why?
|
| Radiography | 1 | 2011 | 75 | 0.100 |
Why?
|
| Head | 1 | 2011 | 30 | 0.100 |
Why?
|
| Cyclopentolate | 1 | 1990 | 1 | 0.100 |
Why?
|
| Postpartum Hemorrhage | 1 | 2010 | 7 | 0.100 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 43 | 0.100 |
Why?
|
| Radiation Dosage | 2 | 2021 | 32 | 0.100 |
Why?
|
| DNA, Intergenic | 1 | 2010 | 10 | 0.090 |
Why?
|
| Mice, SCID | 2 | 2021 | 143 | 0.090 |
Why?
|
| Brain | 1 | 2018 | 1268 | 0.090 |
Why?
|
| Introns | 1 | 2010 | 67 | 0.090 |
Why?
|
| Neuroimmunomodulation | 1 | 2010 | 13 | 0.090 |
Why?
|
| Middle Aged | 2 | 2021 | 9642 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2011 | 288 | 0.090 |
Why?
|
| Cerebellum | 1 | 2010 | 69 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 63 | 0.090 |
Why?
|
| Mammals | 1 | 2010 | 96 | 0.090 |
Why?
|
| Azo Compounds | 1 | 2009 | 18 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2010 | 140 | 0.090 |
Why?
|
| Palladium | 1 | 2009 | 27 | 0.090 |
Why?
|
| India | 3 | 2021 | 82 | 0.090 |
Why?
|
| Adult | 3 | 2021 | 11034 | 0.090 |
Why?
|
| Ribosomes | 1 | 2008 | 27 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 68 | 0.080 |
Why?
|
| DNA, Catalytic | 1 | 2008 | 2 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 1490 | 0.080 |
Why?
|
| Binding Sites | 2 | 2021 | 597 | 0.080 |
Why?
|
| Imidazoles | 1 | 2009 | 124 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2010 | 249 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 67 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 455 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2010 | 213 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 901 | 0.080 |
Why?
|
| Models, Chemical | 1 | 2009 | 201 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 281 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2008 | 148 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2009 | 347 | 0.070 |
Why?
|
| Mutation | 3 | 2021 | 1023 | 0.070 |
Why?
|
| Hippocampus | 1 | 2010 | 546 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2021 | 1442 | 0.070 |
Why?
|
| Aging | 1 | 2010 | 639 | 0.070 |
Why?
|
| Protein Binding | 2 | 2021 | 913 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2008 | 486 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2008 | 1152 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2024 | 54 | 0.060 |
Why?
|
| Pakistan | 1 | 2022 | 21 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2019 | 897 | 0.050 |
Why?
|
| PPAR alpha | 1 | 2022 | 42 | 0.050 |
Why?
|
| Triglycerides | 1 | 2022 | 129 | 0.050 |
Why?
|
| CpG Islands | 2 | 2012 | 91 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2021 | 75 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2021 | 79 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 9 | 0.050 |
Why?
|
| Cholesterol | 1 | 2022 | 194 | 0.050 |
Why?
|
| Karyopherins | 1 | 2020 | 6 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2020 | 28 | 0.050 |
Why?
|
| Lipids | 1 | 2022 | 222 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2020 | 58 | 0.050 |
Why?
|
| Staphylococcal Protein A | 1 | 2020 | 1 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2022 | 333 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2020 | 39 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2020 | 135 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 161 | 0.050 |
Why?
|
| CHO Cells | 1 | 2020 | 107 | 0.050 |
Why?
|
| Kinetics | 1 | 2021 | 650 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2020 | 197 | 0.050 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2019 | 1 | 0.050 |
Why?
|
| Hexokinase | 1 | 2019 | 9 | 0.040 |
Why?
|
| Micronucleus Tests | 1 | 2019 | 10 | 0.040 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2019 | 5 | 0.040 |
Why?
|
| Pyruvate Dehydrogenase (Lipoamide)-Phosphatase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2019 | 16 | 0.040 |
Why?
|
| RNA Polymerase II | 2 | 2009 | 24 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2019 | 58 | 0.040 |
Why?
|
| Heme | 1 | 2019 | 69 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2020 | 351 | 0.040 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2008 | 11 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2019 | 60 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 63 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 490 | 0.040 |
Why?
|
| Plasmodium vivax | 1 | 1998 | 4 | 0.040 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2018 | 2 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 73 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2019 | 87 | 0.040 |
Why?
|
| RNA Interference | 1 | 2019 | 225 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 211 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2018 | 323 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 407 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 184 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 480 | 0.040 |
Why?
|
| Hela Cells | 1 | 2018 | 344 | 0.040 |
Why?
|
| Malaria | 1 | 1998 | 68 | 0.040 |
Why?
|
| Time Factors | 2 | 2012 | 1681 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 391 | 0.040 |
Why?
|
| Plasmodium falciparum | 1 | 1998 | 121 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 649 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 420 | 0.040 |
Why?
|
| Base Sequence | 2 | 2008 | 932 | 0.040 |
Why?
|
| Prognosis | 1 | 2018 | 707 | 0.040 |
Why?
|
| Pregnancy | 2 | 2011 | 1503 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 545 | 0.030 |
Why?
|
| Hospitalization | 1 | 1998 | 370 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 114 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2014 | 55 | 0.030 |
Why?
|
| Risk | 1 | 2014 | 256 | 0.030 |
Why?
|
| Heterochromatin | 1 | 2012 | 12 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 48 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2014 | 226 | 0.030 |
Why?
|
| Homozygote | 1 | 2012 | 75 | 0.030 |
Why?
|
| Disease Progression | 1 | 2014 | 580 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2011 | 27 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2011 | 87 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2011 | 73 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 152 | 0.020 |
Why?
|
| Lysine | 1 | 2011 | 104 | 0.020 |
Why?
|
| Placenta | 1 | 2011 | 91 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 638 | 0.020 |
Why?
|
| Administration, Topical | 1 | 1990 | 39 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2011 | 167 | 0.020 |
Why?
|
| Ophthalmic Solutions | 1 | 1990 | 18 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 162 | 0.020 |
Why?
|
| Testis | 1 | 2011 | 185 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2011 | 154 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 608 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 213 | 0.020 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2010 | 8 | 0.020 |
Why?
|
| Thyroxine | 1 | 2010 | 17 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2010 | 38 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 63 | 0.020 |
Why?
|
| Alleles | 1 | 2010 | 284 | 0.020 |
Why?
|
| Photochemistry | 1 | 2009 | 61 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 383 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2008 | 12 | 0.020 |
Why?
|
| RNA Stability | 1 | 2008 | 24 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2009 | 162 | 0.020 |
Why?
|
| Enterovirus B, Human | 1 | 2008 | 2 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 237 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2008 | 139 | 0.020 |
Why?
|
| Estradiol | 1 | 2010 | 244 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2008 | 132 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 142 | 0.020 |
Why?
|
| Plasmids | 1 | 2008 | 233 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2008 | 172 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2010 | 1353 | 0.020 |
Why?
|
| Virus Replication | 1 | 2008 | 261 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2009 | 751 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 3414 | 0.010 |
Why?
|
| Quinine | 1 | 1998 | 10 | 0.010 |
Why?
|
| Chloroquine | 1 | 1998 | 19 | 0.010 |
Why?
|
| Malaria, Cerebral | 1 | 1998 | 31 | 0.010 |
Why?
|
| Urban Health | 1 | 1998 | 86 | 0.010 |
Why?
|
| Antimalarials | 1 | 1998 | 48 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1998 | 608 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1998 | 871 | 0.010 |
Why?
|
| Infant | 1 | 1998 | 1014 | 0.010 |
Why?
|